{"id":"F2007L01602","name":"Therapeutic Goods Act 1989 - Order under subsection 3(1) – Definition of British Pharmacopoeia (30/05/2007)","slug":"therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-30-05-2007","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":66177,"registerId":"commonwealth-F2007L01602-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods Act 1989 - Order under subsection 3(1) – Definition of British Pharmacopoeia (30/05/2007)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n![](image.001.png)\n\n \n\n \n\nTHERAPEUTIC GOODS ACT 1989\n\n \n\nORDER UNDER SUBSECTION 3(1) – DEFINITION OF BRITISH PHARMACOPOEIA\n\n \n\nI, DAVID GRAHAM, delegate of the Minister for Health and Ageing for the purposes of the exercise of the Minister’s power under the definition of “British Pharmacopoeia” in subsection 3(1) of the Therapeutic Goods Act 1989 (“the Act”) and acting under that provision, HEREBY SPECIFY that on and from 1 July 2007 the definition of “British Pharmacopoeia” in the Act shall be the British Pharmacopoeia 2007.\n\n \n\n \n\nDated this  30th  day of May 2007\n\n \n\n \n\n \n\n \n\n \n\n \n\nDAVID GRAHAM\n\nNational Manager\n\nTherapeutic Goods Administration\n\n(Delegate of the Minister for Health and Ageing)\n\n \n","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":916},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This instrument maintains the existing scope of the Therapeutic Goods Act by updating a standard reference to its current edition, rather than expanding the legislation's reach or introducing new regulatory requirements."},"complexity_factors":["Single operative provision with no subsections or conditions","No defined terms within the instrument itself","No cross-references to other legislation beyond the empowering provision (subsection 3(1))","Straightforward administrative update of a statutory reference"],"plain_english_summary":"This Order updates the Therapeutic Goods Act 1989 to specify that “British Pharmacopoeia” means the British Pharmacopoeia 2007 from 1 July 2007. \n\nThat change matters because the Pharmacopoeia sets legally referenced quality and testing standards for medicines; it chiefly affects pharmaceutical companies and the TGA, who must meet the 2007 edition’s requirements."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-30-05-2007","history":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-30-05-2007/history","analysis":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-30-05-2007/analysis","conflicts":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-30-05-2007/conflicts","importantCases":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-30-05-2007/important-cases","documents":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-30-05-2007/documents"}}